SARS-CoV Spike Antibody Cat. No.: 3219

Availability: In stock

$0.00

 Price Options

* Required Fields

$0.00
psi-iconSpecifications
HOST SPECIES:Rabbit
SPECIES REACTIVITY: Virus
HOMOLOGY: Predicted reactivity based on immunogen sequence: SARS-CoV2 Spike protein: (14%)
IMMUNOGEN: Anti-SARS-CoV Spike antibody (3219) was raised against a peptide corresponding to 14 amino acids near the amino of SARS-CoV Spike glycoprotein.

The immunogen is located within the first 50 amino acids of SARS-CoV Spike.
TESTED APPLICATIONS: ELISA
APPLICATIONS: SARS-CoV Spike antibody can be used for the detection of SARS-CoV Spike protein in ELISA. It will detect 5 ng of free peptide at 1 μg/mL.

psi-iconProperties
PURIFICATION:SARS-CoV Spike Antibody is affinity chromatography purified via peptide column.
CLONALITY:Polyclonal
ISOTYPE:IgG
CONJUGATE:Unconjugated
PHYSICAL STATE:Liquid
BUFFER:SARS-CoV Spike Antibody is supplied in PBS containing 0.02% sodium azide.
CONCENTRATION:1 mg/mL
STORAGE CONDITIONS:SARS-CoV Spike antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

psi-iconAdditional Info
OFFICIAL SYMBOL:S
ALTERNATE NAMES:SARS-CoV Spike Antibody: E2, Spike glycoprotein, E2, S glycoprotein
ACCESSION NO.:P59594
PROTEIN GI NO.:30173397
GENE ID:1489668
USER NOTE:Optimal dilutions for each application to be determined by the researcher.
psi-iconBackground and References
BACKGROUND:SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
REFERENCES:1) Marra et al. Science 2003;300:1399-404.
2) Rota et al. Science 2003;300:1394-9.
3) Navas-Nartin et al. J Neurovirol. 2004;10:75-85.
4) Li et al. Nature 2003;426:450-4.

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.